Otsuka reports long-term kidney data key to Voyxact's bid for full approval

July 2, 2026 10:50 AM EDT R&DFDA+ Ot­su­ka re­ports long-term kid­ney da­ta key to Voyx­ac­t's bid for full ap­proval Max Gelman Senior Editor Ot­su­ka on Thurs­day re­port­ed new long-term da­ta that it hopes will con­vert an ac­cel­er­at­ed ap­proval to a full green light in kid­ney dis­ease. The com­pa­ny … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER